Navigation Links
Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia

FARMINGTON, Conn., May 15, 2013 /PRNewswire-iReach/ -- World Pharma Congress is celebrating 12 years of preclinical research with its annual event covering the latest in drug targets, high-throughput screening, lead optimization, ADME and drug safety. Years of effectively covering the latest preclinical strategies and technologies that drive better predictions has culminated in priming this year's event to move further downstream into early formulations and drug delivery.


Why Attend?

Preclinical efforts targeted towards discovery, screening, safety and drug delivery

Active brainstorming and networking opportunity for experts from industry and academia Interactive pre-conference short courses taught by experts in an informal setting

Updates from leading technology and service providers on the latest tools and services

Informative roundtables, panels, posters, stimulating communication and collaboration

For further featured conference programs, please visit links below:

Predictive Preclinical Models in Oncology

Pain Therapeutics

Drug Delivery and Formulation

Predicting Drug-Induced Organ Toxicities Using Functional Assays, Models and Markers

Integrating Molecular Imaging Technologies to Improve Preclinical Findings

Easy conference registration is available through Global Information's online registration system at

Event Organizers: Need to reach biotech, pharmaceutical, and healthcare executives in Asia?

For over a decade, Global Information Inc, through our GlobalReach event service, has connected conference and event organizers in the West with attendees, exhibitors, and sponsors in the East. Offering affordable fixed-price translation, localization, and conference marketing services, GlobalReach bridges the gap between cultures to connect organizers with the fastest growing markets on the planet. Visit our website or contact us today to learn more.

About Global Information Inc. Global Information (GII) ( is an information service company partnering with over 400 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 30 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Joe Malley Global Information, Inc., 1-860-674-8796,

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 4th Annual Advancing Global Clinical Trials Conference is Announced
2. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
3. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
4. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
5. Preclinical study shows heroin vaccine blocks relapse
6. Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
7. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
8. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
9. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):